Table 3: Comparative analysis of combined genotypes of acute stroke patients and healthy controls.
|
Genotypes |
Acute stroke patients |
Healthy controls |
OR (CI 95%) |
p |
|
|
(n = 107) |
(n = 99) |
||||
|
n (%) |
n (%) |
||||
|
Q192R-L55M |
|
|
|
|
|
|
QQ-LL |
23 (23.4) |
17 (17.2) |
1.47 (0.74-2.93) |
0.271 |
|
|
QR-LL |
13 (12.1) |
17 (17.2) |
0.67 (0.31-1.46) |
0.309 |
|
|
RR-LL |
6 (5.6) |
5 (5.1) |
1.12 (0.33-3.78) |
0.859 |
|
|
QQ-LM |
39 (36.4) |
33 (33.3) |
1.15 (0.65-2.04) |
0.639 |
|
|
QR-LM |
8 (7.5) |
17 (17.2) |
0.39 (0.16-0.95) |
0.033 |
|
|
QQ-MM |
14 (13.1) |
8 (8.1) |
1.71 (0.68-4.28) |
0.246 |
|
|
QR-MM |
2 (1.9) |
2 (2.0) |
0.92 (0.09-9.02) |
0.941 |
|
Data were analyzed by χ2 or Fisher'exact tests. The results that are statistically significant are shown in boldface.